Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Mersana Therapeutics Inc (MRSN)

Mersana Therapeutics Inc (MRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 274,243
  • Shares Outstanding, K 123,533
  • Annual Sales, $ 36,860 K
  • Annual Income, $ -171,670 K
  • EBIT $ -80 M
  • EBITDA $ -83 M
  • 60-Month Beta 1.50
  • Price/Sales 7.44
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 132.49% ( +50.02%)
  • Historical Volatility 110.70%
  • IV Percentile 69%
  • IV Rank 32.27%
  • IV High 376.19% on 04/26/24
  • IV Low 16.36% on 09/09/24
  • Put/Call Vol Ratio 3.50
  • Today's Volume 18
  • Volume Avg (30-Day) 244
  • Put/Call OI Ratio 1.11
  • Today's Open Interest 12,345
  • Open Int (30-Day) 12,285

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.16
  • Number of Estimates 5
  • High Estimate -0.11
  • Low Estimate -0.21
  • Prior Year -0.16
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.80 +10.00%
on 11/05/24
2.83 -30.04%
on 11/13/24
-0.12 (-5.71%)
since 10/21/24
3-Month
1.28 +54.69%
on 09/06/24
2.83 -30.04%
on 11/13/24
+0.59 (+42.45%)
since 08/21/24
52-Week
1.22 +62.30%
on 08/14/24
6.28 -68.47%
on 03/11/24
+0.40 (+25.32%)
since 11/21/23

Most Recent Stories

More News
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results

MRSN : 1.98 (-10.81%)
Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024

MRSN : 1.98 (-10.81%)
1 'Strong Buy' Russell 2000 Stock With 188% Upside Potential

As a part of the annual Russell Index reconstitution, this ‘Strong Buy’-rated penny stock is one of the new entrants to the Russell 2000 Index.

ADCT : 1.9400 (-2.02%)
$SPX : 5,948.71 (+0.53%)
MRSN : 1.98 (-10.81%)
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race

Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant...

DTC.CN : 0.5200 (-5.45%)
MGNX : 3.21 (-2.13%)
IOVA : 8.24 (+1.23%)
MRTX : 58.70 (-0.17%)
MRSN : 1.98 (-10.81%)
DTCFF : 0.4093 (+0.29%)
LLY : 749.92 (-0.46%)
PFE : 25.13 (+0.76%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. ("Mersana" or the "Company") (NASDAQ: MRSN). Such...

MRSN : 1.98 (-10.81%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. ("Mersana" or the "Company") (NASDAQ: MRSN). Such...

MRSN : 1.98 (-10.81%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. ("Mersana" or the "Company") (NASDAQ: MRSN). Such...

MRSN : 1.98 (-10.81%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. ("Mersana" or the "Company") (NASDAQ: MRSN). Such...

MRSN : 1.98 (-10.81%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. ("Mersana" or the "Company") (NASDAQ: MRSN). Such...

MRSN : 1.98 (-10.81%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. ("Mersana" or the "Company") (NASDAQ: MRSN). Such...

MRSN : 1.98 (-10.81%)

Business Summary

Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.

See More

Key Turning Points

3rd Resistance Point 2.51
2nd Resistance Point 2.40
1st Resistance Point 2.19
Last Price 1.98
1st Support Level 1.87
2nd Support Level 1.76
3rd Support Level 1.55

See More

52-Week High 6.28
Fibonacci 61.8% 4.35
Fibonacci 50% 3.75
Fibonacci 38.2% 3.15
Last Price 1.98
52-Week Low 1.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar